A woman is diagnosed with a pituitary microadenoma and has elevated serum prolactin levels. She presents with secondary amenorrhea and infertility. What is the most likely mechanism by which hyperprolactinemia causes these symptoms?

Explanation

## Correct Answer: C. Decreased GnRH secretion from the hypothalamus Hyperprolactinemia suppresses GnRH (gonadotropin-releasing hormone) secretion from the hypothalamus through a dopamine-dependent mechanism. Prolactin inhibits dopamine release from the hypothalamus; dopamine is the primary inhibitor of prolactin secretion (hence dopamine agonists like bromocriptine are first-line treatment). When prolactin is elevated, it creates a negative feedback loop that reduces GnRH pulsatility and frequency. This decreased GnRH leads to reduced LH and FSH secretion, resulting in hypogonadism, anovulation, and secondary amenorrhea. The mechanism is NOT direct antagonism of estrogen or increased LH—rather, it is suppression of the entire hypothalamic-pituitary-gonadal (HPG) axis at the level of GnRH. In Indian clinical practice, prolactinomas are the most common functional pituitary adenomas, and dopamine agonists (bromocriptine, cabergoline) are the standard first-line treatment because they restore dopamine inhibition of prolactin and thereby restore normal GnRH pulsatility and fertility. ## Why the other options are wrong **A. Increased LH secretion from the pituitary** — This is wrong because hyperprolactinemia causes the opposite—it decreases LH secretion by suppressing GnRH. The NBE trap here is that students may confuse prolactin's effect with a direct stimulation of gonadotropins. In reality, prolactin suppresses the entire HPG axis, leading to low LH and FSH, not elevated LH. **B. Antagonism of estrogen receptors** — This is wrong because prolactin does not antagonize estrogen receptors; it acts centrally on the hypothalamus to suppress GnRH. This option may trap students who think of prolactin as a direct peripheral hormone affecting target tissues. The primary mechanism is neuroendocrine (hypothalamic suppression), not receptor antagonism at the tissue level. **D. Increased pulsatile FSH secretion** — This is wrong because hyperprolactinemia decreases FSH secretion, not increases it. Decreased GnRH pulsatility leads to reduced FSH and LH. The NBE trap is pairing prolactinoma with 'increased' gonadotropins, when the clinical reality is hypogonadotropic hypogonadism with low gonadotropins and amenorrhea. ## High-Yield Facts - **Prolactin suppresses GnRH** through inhibition of hypothalamic dopamine release; dopamine is prolactin-inhibiting factor (PIF). - **Bromocriptine and cabergoline** are first-line dopamine agonists for prolactinomas in India; they restore GnRH pulsatility and fertility. - **Prolactinomas account for ~40% of pituitary adenomas** in India and are the most common cause of secondary amenorrhea due to hyperprolactinemia. - **Hypogonadotropic hypogonadism** (low LH, FSH, and estrogen) is the endocrine pattern in hyperprolactinemia, not hypergonadotropic. - **GnRH pulsatility is critical**—even with normal GnRH levels, loss of pulsatile secretion due to prolactin suppression causes amenorrhea and infertility. ## Mnemonics **PIF = Prolactin-Inhibiting Factor** Dopamine is the only pituitary hormone with tonic inhibition (PIF). High prolactin → low dopamine → loss of GnRH pulsatility → amenorrhea. Use this to remember that prolactin works via dopamine suppression, not direct gonadal effects. **DOPA-GONE** Dopamine Agonists restore GnRH (Gone = suppressed by prolactin). Bromocriptine/Cabergoline → dopamine ↑ → prolactin ↓ → GnRH pulsatility restored → fertility returns. ## NBE Trap NBE pairs prolactinoma with 'increased gonadotropins' (option A) or 'increased FSH' (option D) to trap students who confuse prolactin's effect with a stimulatory hormone. The actual mechanism is suppression of the entire HPG axis, resulting in hypogonadotropic hypogonadism with low LH and FSH. ## Clinical Pearl In Indian clinical practice, a woman presenting with secondary amenorrhea and infertility should always have serum prolactin checked. If elevated, dopamine agonists (bromocriptine 2.5–5 mg daily or cabergoline 0.5 mg twice weekly) restore ovulation and fertility in >90% of cases—making this a highly treatable cause of infertility in India. _Reference: Harrison Ch. 375 (Pituitary Disorders); DC Dutta's Textbook of Obstetrics Ch. 3 (Amenorrhea); KD Tripathi Pharmacology Ch. 32 (Dopamine Agonists)_